Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1962 1
1963 32
1964 60
1965 30
1966 39
1967 64
1968 79
1969 124
1970 153
1971 186
1972 179
1973 169
1974 230
1975 174
1976 227
1977 194
1978 251
1979 251
1980 258
1981 249
1982 246
1983 321
1984 413
1985 395
1986 353
1987 566
1988 969
1989 1136
1990 1238
1991 1195
1992 1337
1993 1445
1994 1685
1995 1640
1996 1697
1997 1863
1998 1710
1999 1675
2000 1935
2001 2172
2002 2060
2003 2313
2004 2446
2005 2591
2006 2481
2007 2517
2008 2559
2009 2811
2010 3044
2011 3406
2012 3481
2013 3603
2014 3936
2015 4099
2016 3903
2017 3866
2018 3541
2019 3379
2020 3949
2021 4168
2022 4368
2023 4236
2024 1654

Text availability

Article attribute

Article type

Publication date

Search Results

93,441 results

Results by year

Filters applied: . Clear all
Page 1
Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer.
Konstantinopoulos PA, Ceccaldi R, Shapiro GI, D'Andrea AD. Konstantinopoulos PA, et al. Cancer Discov. 2015 Nov;5(11):1137-54. doi: 10.1158/2159-8290.CD-15-0714. Epub 2015 Oct 13. Cancer Discov. 2015. PMID: 26463832 Free PMC article. Review.
Approximately 50% of epithelial ovarian cancers (EOC) exhibit defective DNA repair via homologous recombination (HR) due to genetic and epigenetic alterations of HR pathway genes. ...
Approximately 50% of epithelial ovarian cancers (EOC) exhibit defective DNA repair via homologous recombination (HR) due to genetic a …
Ovarian cancer in pregnancy.
Fruscio R, de Haan J, Van Calsteren K, Verheecke M, Mhallem M, Amant F. Fruscio R, et al. Best Pract Res Clin Obstet Gynaecol. 2017 May;41:108-117. doi: 10.1016/j.bpobgyn.2016.09.013. Epub 2016 Oct 1. Best Pract Res Clin Obstet Gynaecol. 2017. PMID: 28029502 Review.
Chemotherapy should be a combination of carboplatin and paclitaxel in epithelial ovarian cancer patients and a combination of cisplatin, vinblastin and bleomycin in non-epithelial ovarian cancer. ...
Chemotherapy should be a combination of carboplatin and paclitaxel in epithelial ovarian cancer patients and a combination of cisplat …
MR Imaging of Thymic Epithelial Neoplasms.
Carter BW, Lichtenberger JP 3rd, Benveniste MF. Carter BW, et al. Top Magn Reson Imaging. 2018 Apr;27(2):65-71. doi: 10.1097/RMR.0000000000000160. Top Magn Reson Imaging. 2018. PMID: 29613961 Review.
Thymic epithelial neoplasms are malignant lesions that originate from the thymus and include thymoma, thymic carcinoma, and thymic neuroendocrine tumors. ...At least 15 different stage classifications have been proposed for thymic epithelial neoplasms …
Thymic epithelial neoplasms are malignant lesions that originate from the thymus and include thymoma, thymic carcinoma, and th …
PIK3CA mutations in vascular malformations.
Castillo SD, Baselga E, Graupera M. Castillo SD, et al. Curr Opin Hematol. 2019 May;26(3):170-178. doi: 10.1097/MOH.0000000000000496. Curr Opin Hematol. 2019. PMID: 30855339 Free article. Review.
SUMMARY: Oncogenic mutations on PIK3CA causing lymphatic malformations and venous malformations are also frequently found in epithelial cancer. Thus, fundamental research done in the cancer field during the past decades might be applied to the understanding of lymphatic ma …
SUMMARY: Oncogenic mutations on PIK3CA causing lymphatic malformations and venous malformations are also frequently found in epithelial …
Systemic treatment for thymic malignancies.
Girard N, Merveilleux du Vignaux C. Girard N, et al. Curr Opin Oncol. 2017 Mar;29(2):112-117. doi: 10.1097/CCO.0000000000000355. Curr Opin Oncol. 2017. PMID: 28027106 Review.
PURPOSE OF REVIEW: The management of thymic epithelial tumors is a paradigm of multidisciplinary collaboration. ...RECENT FINDINGS: More options have become available for advanced, refractory, and recurrent thymic epithelial tumors, which include cytotoxic agents su …
PURPOSE OF REVIEW: The management of thymic epithelial tumors is a paradigm of multidisciplinary collaboration. ...RECENT FINDINGS: M …
Thymic Epithelial Neoplasms: Tumor-Node-Metastasis Staging.
Benveniste MFK, Betancourt Cuellar SL, Carter BW, Strange CD, Marom EM. Benveniste MFK, et al. Radiol Clin North Am. 2021 Mar;59(2):183-192. doi: 10.1016/j.rcl.2020.11.006. Radiol Clin North Am. 2021. PMID: 33551080 Review.
Thymic epithelial neoplasms are a group of malignant tumors that includes thymoma, thymic carcinoma, and thymic neuroendocrine tumors. ...
Thymic epithelial neoplasms are a group of malignant tumors that includes thymoma, thymic carcinoma, and thymic neuroendocrine …
Epithelial ovarian cancer.
Ng JS, Low JJ, Ilancheran A. Ng JS, et al. Best Pract Res Clin Obstet Gynaecol. 2012 Jun;26(3):337-45. doi: 10.1016/j.bpobgyn.2011.12.005. Epub 2012 Jan 24. Best Pract Res Clin Obstet Gynaecol. 2012. PMID: 22281513 Review.
The incidence of epithelial ovarian cancer in women aged 40 years and younger is 3-17%. The management of these women is challenging and requires balancing the need to treat epithelial ovarian cancer adequately and preserving reproductive potential. ...
The incidence of epithelial ovarian cancer in women aged 40 years and younger is 3-17%. The management of these women is challenging …
Role of radiation therapy.
Eifel PJ. Eifel PJ. Best Pract Res Clin Obstet Gynaecol. 2017 May;41:118-125. doi: 10.1016/j.bpobgyn.2016.11.005. Epub 2016 Nov 25. Best Pract Res Clin Obstet Gynaecol. 2017. PMID: 27986398 Review.
Because most patients with epithelial ovarian cancer have advanced disease at the time of initial diagnosis, radiation therapy usually does not play a major role in their treatment. ...There is strong evidence that radiation therapy can be used to achieve prolonged disease …
Because most patients with epithelial ovarian cancer have advanced disease at the time of initial diagnosis, radiation therapy usuall …
Low-grade serous ovarian cancer: A review.
Kaldawy A, Segev Y, Lavie O, Auslender R, Sopik V, Narod SA. Kaldawy A, et al. Gynecol Oncol. 2016 Nov;143(2):433-438. doi: 10.1016/j.ygyno.2016.08.320. Epub 2016 Aug 28. Gynecol Oncol. 2016. PMID: 27581327 Review.
Epithelial ovarian cancers can be divided into the more common, aggressive type II cancers and the less common, slow-growing type I cancers. ...
Epithelial ovarian cancers can be divided into the more common, aggressive type II cancers and the less common, slow-growing type I c …
Pathology of uterine malignancies.
Brown L. Brown L. Clin Oncol (R Coll Radiol). 2008 Aug;20(6):433-47. doi: 10.1016/j.clon.2008.04.005. Epub 2008 May 21. Clin Oncol (R Coll Radiol). 2008. PMID: 18499412 Review.
This overview covers epithelial, stromal and mesenchymal malignancies of the body of the uterus, excluding the cervix. ...The concept of carcinosarcoma representing a metaplastic adenocarcinoma of the endometrium that behaves more like a carcinoma than a sarcoma is explain …
This overview covers epithelial, stromal and mesenchymal malignancies of the body of the uterus, excluding the cervix. ...The concept …
93,441 results
You have reached the last available page of results. Please see the User Guide for more information.